Patent · US Active

Inhibitors of phosphatidylinositol 3-kinase gamma

US10858355B2 · kind B2 · utility

0Cited by

1References

4Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Mickael Mogemark · Mölndal, SE
Nils Pemberton · Umeå, SE
Jens PETERSEN · Mölndal, SE
Matthew Perry · Coalville, GB
Konstantinos KARABELAS · Mölndal, SE
Pavol Zlatoidsky · Mölndal, SE
Rhona Jane Cox · Coalville, GB
Christian Tyrchan · Mölndal, SE

Key dates

Filing date	Mar 9, 2017
Grant date	Dec 8, 2020
Priority date	—
Expiry date	Dec 3, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There are disclosed certain novel compounds (including pharmaceutically acceptable salts thereof), that inhibit phosphatidylinositol 3-kinase gamma (PI3Kδ) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.